ga naar hoofdinhoud
Informatie voor zorgverleners Behandelprotocollen Hodgkin lymfoom (HL) Richtlijnen en literatuur

Richtlijnen

Klik HIER voor de richtlijn 'Hodgkin lymfoom' van de HOVON Lymfoom werkgroep.

Literatuur

  1. Barrington et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. JCO. 2014;32(27):3048-3058
  2. Fanale MA et al. Encouraging activity for R-CHOP in advanced stage nodular lymphocyte-predominant Hodgkin lymphoma. Blood. 2017;130(4):472-477
  3. Santarsieri A et al. The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational study. The Lancet Oncology. 2025; vol 26, issue 1, p98-109
  4. Connors JM et al. Brentuximab vedotin with chemotherapy for stage III of IV Hodgkin's lymphoma. N Engl J Med 2018; 378(4):331-344
  5. Bowers JT et al. Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohort. Blood Adv. 2023; 7(21):6630-6638
  6. Ansell SM et al. Overall survival with brentuximab vedotin in stage III or IV Hodgkin's lymphoma. N Engl J Med 2022; 387:310-320

 

Ga terug naar de HL homepage of lees meer over HL:

Ga terug naar de algemene homepage Behandelprotocollen.